View Older Stories View More Recent Stories

Jul 30, 2014 10:03AM Roth Boosts PT on Regeneron (REGN) to $399 Following ODYSSEY Phase III Data, EYLEA Approval

Jul 28, 2014 02:07PM Roth Capital Comments on Pharmacyclics (PCYC) Following Expanded IMBRUVICA Coverage; Affirms 'Buy' Rating

Jul 28, 2014 10:41AM Roth Affirms 'Buy' Rating on Stemline (STML); Comments on SL-401 News

Jul 28, 2014 09:30AM Pre-Open Stock Movers 7/28: (FDO) (XGTI) (TRLA) Higher; (ACRX) (HZNP) (Z) Lower (more...)

Jul 28, 2014 07:00AM Roth Capital Upgrades Prosensa (RNA) to Buy

Jul 25, 2014 12:33PM Roth Highlights Two Takeaways from SolarCity's (SCTY) ABS Offering; Maintains 'Buy' Rating

Jul 25, 2014 09:14AM Mines Management (MGN) Plans 4,000 Units Offering

Jul 25, 2014 08:58AM Roth Positive on Pharmacyclics (PCYC) Following CHMP Recommendation of Imbruvica

Jul 25, 2014 07:13AM Applied Genetic Technologies (AGTC) Prices 2M Common Offering at $15/Share

Jul 24, 2014 07:05PM AGTC Announces Pricing of Public Offering

Jul 24, 2014 10:43AM Notable Analyst Rating Changes 07/24: (RKUS) (UIS) (SEIC) Upgraded; (ANGI) (QCOM) (BA) Downgraded

Jul 24, 2014 06:45AM Roth Capital Starts CorMedix (CRMD) at Buy

Jul 23, 2014 01:55PM Roth Sees Significant Advantages to TG Therapeutics' (TGTX) TGR-1202 vs. Gilead's (GILD) Zydelig; Reiterates 'Focus Pick' Rating

Jul 23, 2014 08:57AM Ligand (LGND) Pressure on GSK's Promacta Data is Overreaction - Roth Capital

Jul 22, 2014 02:06PM NHLBI Trial Choice Validates Cytori (CYTX) as Top Stem Cell Player - Roth Capital

Jul 22, 2014 11:02AM Notable Analyst Rating Changes 07/22: (AGN) (RLGY) (FANG) Upgraded; (AMZN) (STI) (MTDR) Downgraded

Jul 22, 2014 10:07AM Roth Capital Comments on Ligand (LGND) Following SAGE-547 Update

Jul 22, 2014 09:12AM Roth Capital Raises PT on Galena (GALE) to $8 Following Zuplenz Licensing News

Jul 22, 2014 08:43AM Roth Capital Upgrades Ultra Clean (UCTT) to Buy

Jul 22, 2014 08:14AM CymaBay Therapeutics (CBAY) Prices 4M Follow-On at $5.50/Share

Jul 22, 2014 06:50AM Roth Capital Upgrades Diamondback Energy (FANG) to Buy

Jul 22, 2014 06:27AM Roth Capital Boosts Price Target on TG Therapeutics (TGTX) to $25 on Prelim. TG-1101 Phase 1 Data

Jul 18, 2014 10:56AM Roth Encouraged by Progress with Supinoxin; Maintains 'Buy Rating on Rexahn Pharma (RNN)

Jul 18, 2014 10:28AM Notable Analyst Rating Changes 07/18: (BC) (AMH) (PLXS) Upgraded; (RP) (AMD) (NUS) Downgraded

Jul 18, 2014 09:43AM Roth Capital Affirms Regeneron (REGN) at 'Buy'; Comments on Eylea Phase III VIVID-DME Two-Year Data

Jul 18, 2014 09:22AM Pre-Open Stock Movers 7/18: (ICLD) (GTIV) (SWKS) (GOOG) Higher; (RP) (NQ) (AMD) Lower (more...)

Jul 18, 2014 07:54AM Roth Capital Sees Prelim. Q2 Revenue Numbers from Ligand (LGND) as Just the Beginning of More Success to Come

Jul 18, 2014 06:52AM Roth Capital Starts PEDEVCO Corp (PED) at Buy

Jul 18, 2014 06:50AM Roth Capital Starts Nimble Storage (NMBL) at Buy

Jul 17, 2014 03:28PM Plug Power Shipments/Bookings Going as Expected; Roth Issues Commentary Following Analyst Meetings

Jul 16, 2014 12:13PM Streetinsider.com's Hot Lunchtime Reads 07/16: (AAPL) (MCP) (MNGA) (YHOO)

Jul 16, 2014 10:54AM Roth Capital Encouraged by Removal of CTP-354 Clinical Hold; Has Concert Pharma (CNCE) at 'Buy'

Jul 15, 2014 09:56AM Roth Capital Affirms Peregrine Pharma (PPHM) at 'Buy'; Remains Encouraged by Progress in FY14

Jul 15, 2014 09:27AM No Major N-T Impact Expected on Solars Following WTO Statement on U.S. Antidumping Duties - Roth (SCTY) (JASO) (TSL) (YGE)

Jul 11, 2014 08:35AM Roth Affirms Verastem (VSTM) at 'Buy'; Encouraged by VS-6063's Potential in Mesothelioma, Ovarian Cancer

Jul 11, 2014 08:23AM Tonix Pharmaceuticals (TNXP) Enters 657K Direct Placement at $11.90/Share

Jul 11, 2014 08:12AM Roth Capital Downgrades Golden Minerals Company (AUMN) to Neutral

Jul 10, 2014 12:09PM Streetinsider.com's Hot Lunchtime Reads 07/10: (CYNK) (MSFT) (SRPT) (CYTK)

Jul 10, 2014 11:14AM Roth Capital Keeps Cytokinetics (CYTK) at 'Buy' Following Recent BENEFIT-ALS Update

Jul 10, 2014 08:29AM Roth Capital Affirms Regeneron (REGN) at 'Buy' Following Positive Dupilumab Phase 2b Update

Jul 9, 2014 05:14PM RGS Energy (RGSE) Closes 2.92M Equity Offering at $2.40/Share

Jul 9, 2014 05:00PM RGS Energy Completes $7.0 Million Private Equity Offering

Jul 9, 2014 01:21PM PlacementTracker Publishes First Half 2014 PIPE Market League Tables

Jul 8, 2014 12:07PM Streetinsider.com's Hot Lunchtime Reads 07/08: (PETM) (AAPL) (CNCE) (MSFT)

Jul 8, 2014 10:30AM Roth Capital Keeps Concert Pharma (CNCE) at 'Buy'; SPA Filing is Sign of Confidence in CTP-499

Jul 7, 2014 09:48AM Roth Capital Starts PTC Therapeutics (PTCT) at Buy

Jul 7, 2014 09:36AM Roth Capital 'Encouraged' by Notice of Intent in Cytori's (CYTX) Contract with BARDA

Jul 7, 2014 07:20AM Roth Capital Remains Positive on Spectrum Pharma (SPPI) as Beleodaq Wins Accelerated Approval

Jul 3, 2014 07:47AM RGS Energy (RGSE) Prices $7M Equity Raise

Jul 3, 2014 07:45AM RGS Energy Prices Equity Offering

View More Recent Stories View Older Stories